Skip to main content
Top

Current HIV/AIDS Reports

Issue 4/2018

Content (7 Articles)

The Global Epidemic (SH Vermund, Section Editor)

Federal Response to the Opioid Crisis

Kimberly Johnson, Chris Jones, Wilson Compton, Grant Baldwin, Jennifer Fan, Jonathan Mermin, Jean Bennett

The Global Epidemic (SH Vermund, Section Editor)

Working With Persons Who Inject Drugs and Live in Rural Areas: Implications From China/Vietnam for the USA

Don C. Des Jarlais, Theodore M. Hammett, Binh Kieu, Yi Chen, Jonathan Feelemyer

The Global Epidemic (SH Vermund, Section Editor)

HIV/HCV Co-infection: Burden of Disease and Care Strategies in Appalachia

Jonathan P. Moorman, Matthew R. Krolikowski, Stephanie M. Mathis, Robert P. Pack

The Global Epidemic (SH Vermund, Section Editor)

Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment

Jennifer R. Havens, Sharon L. Walsh, P. Todd Korthuis, David A. Fiellin

The Global Epidemic (SH Vermund, Section Editor)

Young Drug Users: a Vulnerable Population and an Underutilized Resource in HIV/HCV Prevention

Pedro Mateu-Gelabert, H. Guarino, K. Quinn, P. Meylakhs, S. Campos, A. Meylakhs, D. Berbesi, D. Toro-Tobón, E. Goodbody, D.C. Ompad, S. R. Friedman

HIV and Technology (J Simoni and K Horvath, Section Editors)

eHealth to Enhance Treatment Adherence Among Youth Living with HIV

Marta I. Mulawa, Sara LeGrand, Lisa B. Hightow-Weidman

HIV and Technology (J Simoni and K Horvath, Section Editors)

eHealth and Prevention of Mother-to-Child Transmission of HIV

Grace John-Stewart

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine